Speciality

Endocrinology

Product: Januvia® sitagliptin

Disease: Diabetes

Indication: Indicated for patients with type 2 diabetes to improve the control of blood glucose levels. It is used in addition to diet and exercise

Product: Humulin N ®Human insulin (rDNA origin) isophane suspension

Disease: Diabetes

Indication: Indicated in the treatment of patients with diabetes for the control of hyperglycemia

Product: Humulin R ®Regular insulin human  (rDNA origin)

Disease: Diabetes

Indication: Indicated in the treatment of patients with diabetes for the control of hyperglycemia

Product: Humalog ®Insulin lispro

Disease: Diabetes

Indication:                An insulin analog that is indicated in the treatment of patients with diabetes mellitus for the control of hyperglycemia. Humalog has a more rapid onset and a shorter duration of action than Regular human insulin. Therefore, in patients with type 1 diabetes, Humalog should be used in regimens that include a longer-acting insulin. However, in patients with type 2 diabetes, Humalog may be used without a longer-acting insulin when used in combination therapy with sulfonylurea agents.

Humalog may be used in an external insulin pump, but should not be diluted or mixed with any other insulin when used in the pump

Product: Humalog 25 Mix ®Insulin lispro 25%                                   Protaminated lispro (NPL) 75%

Disease: Diabetes

Indication:               Indicated for the treatment of patients with diabetes for the control of hyperglycemia.

Product: Humalog 50 Mix ®Insulin lispro 50% Protaminated lispro (NPL) 50%

Disease: Diabetes

Indication:               Indicated for the treatment of patients with diabetes for the control of hyperglycemia.

Product: Byetta 5 & 10 microgram ®Exenatide

Disease: Diabetes

Indication:               Indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin, a sulfonylurea, a thiazolidedione (TZD), a combination of metformin and a sulfonylurea, or a combination of metformin and a TZD, but have not achieved adequate glycemic control.

Product: Somatropin (rDNA origin) injection

Disease: Growth Hormone Deficiency (GHD)

Indication: Treatment of children with growth failure due to growth hormone deficiency (GHD), Prader-Willi Syndrome, Small for Gestational Age . Adult: Treatment of adults with either adult onset or childhood onset GHD

Product:Thyrogen ®thyrotropin alfa for injection

Disease: Thyroid Cancer

Indication:             Indicated for use as an adjunctive diagnostic tool for serum thyroglobulin (Tg) testing with or without radioiodine imaging in the follow-up of patients with well-differentiated thyroid cancer.

Indicated for use as an adjunctive treatment for radioiodine ablation of thyroid tissue remnants in patients who have undergone a near-total or total thyroidectomy for well-differentiated thyroid cancer and who do not have evidence of metastatic thyroid cancer.